CONTACT: TOM MOORE
Joint Office for Planning, Marketing and Communications
8788 John Pappajohn Pavilion
Iowa City IA 52242
Release: Nov. 13, 2001
Men ages 18 to 50 invited to participate in UI infertility study
IOWA CITY, Iowa -- University of Iowa Health Care researchers are studying
a new medication in the treatment of men diagnosed with infertility.
Jay Sandlow, M.D., an associate professor in the UI department of urology,
will serve as the principal investigator at UI Hospitals and Clinics for the
study. Seven U.S. medical centers will participate in the nationwide research
Each site will enroll approximately 30 or 40 infertile men between the ages
of 18 and 50. Under the randomized study, half of the participants will receive
either a placebo or the investigational medication for a period of six months.
Participants who receive the placebo will eventually have the option of also
receiving the new drug following the completion of the study's initial phase.
For more information, contact the UI department of urology by calling (319)
University of Iowa Health Care describes the partnership between
the UI College of Medicine and the UI Hospitals and Clinics and the patient
care, medical education and research programs and services they provide. Visit
UI Health Care online at www.uihealthcare.com.